XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement Of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities    
Net income (loss) $ (5,432) $ 185,386
Add (deduct) adjustments to reconcile net income to cash flows from operating activities    
Depreciation, amortization and accretion 429,486 496,280
Bad debts expense 52,098 35,187
Stock-based compensation expense 15,488 12,902
Deferred income taxes, net (33,346) (21,246)
Equity in earnings of unconsolidated entities (72,117) (62,694)
Distributions from unconsolidated entities 65,569 47,635
(Gain) loss on asset disposals, net 10,333 13,935
(Gain) loss on sale of business and other exit costs, net (4,289) (296,103)
(Gain) loss on investments   (14,518)
(Gain) loss on license sales and exchanges (91,446)  
Noncash interest expense 1,014 997
Other operating activities 3 505
Changes in assets and liabilities from operations    
Accounts receivable 40,459 (5,781)
Inventory 38,674 (8,105)
Accounts payable (43,132) 58,204
Customer deposits and deferred revenues 13,139 7,897
Accrued taxes 1,049 150,425
Accrued interest 22 2,172
Other assets and liabilities (101,930) (81,586)
Cash flows from operating activities 315,642 521,492
Cash flows from investing activities    
Cash used for additions to property, plant and equipment (339,907) (384,281)
Cash paid for acquisitions and licenses (18,681) (14,150)
Cash received from divestitures 125,905 480,000
Cash received for investments 10,000 15,000
Other investing activities 3,720 14,127
Cash flows from investing activities (218,963) 110,696
Cash flows from financing activities    
Repayment of long-term debt (589) (605)
TDS Common Shares reissued for benefit plans, net of tax payments 401 776
U.S. Cellular Common Shares reissued for benefit plans, net of tax payments 830 (2,206)
Repurchase of TDS Common Shares (20,090)  
Repurchase of U.S. Cellular Common Shares (8,298) (18,425)
Dividends paid to TDS shareholders (29,107) (27,598)
U.S. Cellular dividends paid to noncontrolling public shareholders   (75,235)
Distributions to noncontrolling interests (482) (3,292)
Other financing activities 5,502 331
Cash flows from financing activities (51,833) (126,254)
Net increase in cash and cash equivalents 44,846 505,934
Cash and cash equivalents    
Beginning of period 830,014 740,481
End of period $ 874,860 $ 1,246,415